Nyumbani › Saratani ya Prostate › Oregon › Eugene
Majaribio ya kliniki ya Saratani ya Prostate katika Eugene, OR
Masomo 3 ya Saratani ya Prostate yanatafuta washiriki katika vituo vya Eugene na maeneo yake (ndani ya takriban maili 30). Fungua somo kuona nani anaweza kujiunga na jinsi ya kuwasiliana na timu ya utafiti.
Maandishi rasmi ya utafiti (Kiingereza)
Unavutia washiriki kwa utafiti hapa? Weka juu ya ukurasa huu — $99 kwa siku 30 →
Open-label Study Comparing AAA817 Versus Standard of Care in the Treatment of Previously Treated PSMA-positive mCRPC Adults Who Have Disease Progressed on or After [177Lu]Lu-PSMA Targeted Therapy
InaajiriHatua 2/3
- Oregon Urology Institute, Springfield · Mi 3 mbali
A Study of Metastases Free Survival With Saruparib vs Placebo Added to a Standard RT/ADT in Men With High-risk Prostate Cancer With a BRCA Mutation
InaajiriHatua 3
- Research Site, Springfield · Mi 3 mbali
Positron Emission Tomography Using 64Cu-SAR-bisPSMA in Participants With High-risk Prostate Cancer Prior to Radical Prostatectomy
InaajiriHatua 3
- Oregon Urology, Springfield · Mi 3 mbali
Majaribio ya Saratani ya Prostate katika miji mingine
- New York City, NYUtafiti 103
- Houston, TXUtafiti 76
- Los Angeles, CAUtafiti 61
- Boston, MAUtafiti 59
- St. Louis, MOUtafiti 46
- Chicago, ILUtafiti 45
- San Francisco, CAUtafiti 45
- Philadelphia, PAUtafiti 44
- Baltimore, MDUtafiti 43
- Nashville, TNUtafiti 42
- Seattle, WAUtafiti 42
- Washington, DCUtafiti 38
Masomo mengine katika Eugene
- Saratani ya Mapafu Isiyo na Selu NdogoUtafiti 13
- Kansari ya MayaiUtafiti 9
- Saratani ya EndometrialUtafiti 8
- Saratani ya MatitiUtafiti 7
- Leukemia ya Limfosaiti ya Muda MrefuUtafiti 6
- Multiple MyelomaUtafiti 6
- Saratani ya MetastasiUtafiti 6
- Saratani (aina zote)Utafiti 6
- Matumizi ya Dawa na UtegemeziUtafiti 5
- Saratan ya MapafuUtafiti 5
- Uharibifu wa MakulaUtafiti 5
- UnenepuUtafiti 4
Kutoka ClinicalTrials.gov, data iliyopatikana 5 Okt 2026. Kila utafiti una masharti yake ya kufaa; timu ya utafiti huamua nani anaweza kujiunga.